AUTH/3870/1/24: Complainant v AstraZeneca — Allegations about clinical trial material (Out of scope)

📊

Key facts

⌄

Case number	AUTH/3870/1/24
Company	AstraZeneca
Complainant	Not stated
Issue	Allegations about clinical trial material
Complaint received	06 January 2024
Completed	20 September 2024
Appeal	No appeal
Decision	No summary/case report as outwith the scope of the Code
Clauses cited	Not stated
Sanctions	Not stated

Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI

📋

⌄

A complaint was made against AstraZeneca concerning allegations about clinical trial material.
The PMCPA recorded the matter as outwith the scope of the ABPI Code.
No case summary or full report was published because it was outwith scope.

⚖️

⌄

🔒

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value

£249/year

Annual — save £99

£29/mo

Monthly

Join Now — Instant Access

⭐ Charter Member — Until 31 March

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export. £1,999/year £2,499